The Memory Disorders Center at the University of Cincinnati Gardner Neuroscience Institute is committed to advancing treatments that offer the best possible outcomes for patients with Alzheimer’s disease and other causes of cognitive impairment. The Center began enrolling patients in its first clinical trial in 2011, and plans are underway to continue to expand opportunities for people eager to participate in clinical research.

Future studies will likely explore:

  • the implementation of new diagnostic tests
  • new medications
  • the potential for lifestyle modifications to impact cognitive health
  • the clinical impact of memory disorders upon quality of life

Collaboration with our partners within the UC Gardner Neuroscience Institute and the UC College of Medicine has already improved our understanding of cognitive aging.

The Cognitive Aging Program, which is led by Robert Krikorian, PhD, and is part of the UC’s Department of Psychiatry and Behavioral Neuroscience, conducts research studies to identify mechanisms associated with age-related cognitive decline and to improve memory function in middle-aged and older adults. The ultimate aim is to prevent or delay progression to dementia. These studies involve interventions that can be implemented through lifestyle modifications such as dietary manipulation and supplementation as well as pharmaceutical agents.

By working closely with other clinical and laboratory experts, the UC Memory Disorders Center will continue to offer the most innovative, effective and compassionate care.

Clinical Trials

For a list of ongoing clinical trials, click here and search by keyword or category.